Results 111 to 120 of about 23,600 (247)
Изолирование хлорамбуцила из биологического материала [PDF]
В качестве изолирующего агента для извлечения хлорамбуцила из биологического материала предложен ацетон. Определены оптимальные условия изолирования хлорамбуцила из ткани печени и дана количественная оценка результатов ...
Столяров, М. Л. +1 more
core +1 more source
Interferon Alfa in the treatment of B-cell chronic lymphocytic leukemia [PDF]
Adolf, D. +10 more
core +1 more source
Septicaemia with Dysgonic Fermenter -2 (DF-2) bacterium in a compromised host [PDF]
Contains fulltext : 4451.pdf (publisher's version ) (Open ...
Broek, P.J. van den +4 more
core +1 more source
Theragnostic platforms, which integrate therapeutic and diagnostic capabilities, have gained significant interest in drug research because of to their potential advantages.
Thi Ngoc Han Pham +7 more
doaj +1 more source
Theragnostics has become a popular term nowadays, since it enables both diagnosis and therapy at the same time while only using one carrier platform.
Phuong-Thao Dang-Luong +5 more
doaj +1 more source
Luis Felipe Casado,1 Amparo Burgos,2 Eva González-Haba,3 Javier Loscertales,4 Tania Krivasi,5 Javier Orofino,6 Carlos Rubio-Terres,7 Darío Rubio-Rodríguez7 1Hematology Department, Hospital Virgen de la Salud, Toledo, Spain; 2Pharmacy
Casado LF +7 more
doaj
Perspectives and Prospects in the Chemotherapy of Gastrointestinal Cancer [PDF]
5-Flourouracil (5-FU) is the best agent for the treatment of all gastrointestinal cancers but should be used with restraint, since severe toxicity does not guarantee increased response or survival time.
Regelson, William
core +1 more source
Membranöse Glomerulonephritis: Ätiopathogenese, Diagnostik und moderne Therapie [PDF]
Zusammenfassung: Die membranöse Glomerulonephritis (MGN) ist die häufigste Ursache eines nephrotischen Syndroms bei Erwachsenen. Meist liegt eine idiopathische Form vor, doch sollen alle potenziellen Ursachen (in erster Linie Tumoren, Medikamente oder ...
Huynh-Do, U.
core
Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab
Lukáš Smolej 4th Department of Internal Medicine – Hematology, University Hospital Hradec Králové and Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech
Smolej L
doaj

